Home/Products & Solutions/Evaluate Premier Services

Have Questions?

Global Headquarters

Tel: +44 (0)20 7377 0800
Fax: +44 (0)20 7349 5157

North America

Tel: 1-617-573-9450
Fax: 1-617-573-9542


Tel: +81 (0)80-1164-4754

Request a Demo

What our customers are saying

When I think of the future, I think of EvaluatePharma

Senior Director,
Global pharmaceutical company

Evaluate Premier Services


Leader in consensus forecasts and analysis of pharma and biotech

  • Consensus forecasts of leading Wall Street analysts, currently to 2024
  • Must-have data in an integrated, standardized platform
  • Interactive NPV discount cash flow model for asset valuation and Calendar of Events tool


A new standard in medtech industry analysis via a consensus view

  • Consensus forecasts of leading Wall Street analysts, currently to 2024
  • Simplified medtech classification system correlated to FDA and company specified segments
  • Six integrated FDA databases and EU CE Mark approvals

EvaluateClinical Trials

High quality global clinical trial intelligence linked to essential information

  • ClinicalTrials.gov, EudraCT and a Japan Clinical Trials data source
  • Integrated with in-depth EvaluatePharma product and indication information
  • Unique search fields for custom analysis and reporting

EP Vantage

Award-winning commentary and analysis by industry experts

  • Daily round up of share price movements
  • Future market events that will impact product value
  • Searchable news and commentary powered by high quality Evaluate data